The Recall Desk
SevereFDA (Drugs)·D-1060-2013·Announced 2013-09-25

Hydroxocobalamin Injection Recalled Due to Failed Sterility Testing

Northern New England Compounding Pharmacy is recalling one lot of Hydroxocobalamin Injection because third-party testing failed to confirm sterility.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable drug, which poses a significant risk of serious injury or infection, meeting the criteria for a Severe rating.

Plain-English summary

Northern New England Compounding Pharmacy LLC is recalling one lot of Hydroxocobalamin MDV 5 mg/mL Injection, 10 mL vial. The product was distributed in Connecticut.

The recall was initiated because a third-party contract testing laboratory reported failed sterility results for the product. Consequently, the sterility of the medication cannot be assured.

Consumers who possess this specific lot of Hydroxocobalamin Injection should discontinue use and contact their healthcare provider or the recalling pharmacy for further instructions.

The recalled product

Product
Hydroxocobalamin MDV 5 mg/mL (5,000 mcg/mL) Inj., 10 mL vial X 3, Eastern States Compounding Pharmacy, Littleton, NH 03561
Affected units
1

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 08022013@34
  • Exp11/3/2013

Distribution

Distributed in 1 state: